Compare Adaptive Biotechnologies Corp (ADPT) vs Fox Corp Class A (FOXA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Fox Corp Class A — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Fox Corp Class A trades at $61.87 (market cap $24.58B). The key difference: Fox Corp Class A is far larger — about 6.1× Adaptive Biotechnologies Corp's market cap, and Fox Corp Class A pays a 0.93% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | FOXA | |
|---|---|---|
Market Cap | $4.04B | $24.58B |
Sector | Health | Media |
52-Week High | $25.45 | $76.11 |
52-Week Low | $12.30 | $48.79 |
Enterprise Value | $4.10B | $27.94B |
Dividend Yield | — | 0.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
